Detalles de la búsqueda
1.
RRx-001 followed by platinum plus etoposide in patients with previously treated small-cell lung cancer.
Br J Cancer
; 121(3): 211-217, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31231122
2.
Sunitinib in patients with chemotherapy-refractory thymoma and thymic carcinoma: an open-label phase 2 trial.
Lancet Oncol
; 16(2): 177-86, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25592632
3.
Survival and Racial Differences of Non-Small Cell Lung Cancer in the United States Military.
J Gen Intern Med
; 30(10): 1406-12, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-25805503
4.
Images in clinical medicine. Sunitinib-associated hair depigmentation.
N Engl J Med
; 370(17): e27, 2014 Apr 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-24758639
5.
Complete metabolic response of metastatic castration-resistant neuroendocrine carcinoma of the prostate after treatment with RRx-001 and reintroduced platinum doublets.
Clin Case Rep
; 6(12): 2478-2481, 2018 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-30564353
6.
Minocycline-Induced Hyperpigmentation in a Patient Treated with Erlotinib for Non-Small Cell Lung Adenocarcinoma.
Case Rep Oncol
; 10(1): 156-160, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28413391
7.
RRx-001 protects against cisplatin-induced toxicities.
J Cancer Res Clin Oncol
; 143(9): 1671-1677, 2017 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-28417195
8.
Superior Vena Cava Syndrome in a Patient with Small-Cell Lung Cancer: A Case Report.
Case Rep Oncol
; 10(1): 252-257, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28611639
9.
A Case of Paraneoplastic Cushing Syndrome Presenting as Hyperglycemic Hyperosmolar Nonketotic Syndrome.
Case Rep Oncol
; 10(1): 321-324, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28512417
10.
RRx-001 Priming of PD-1 Inhibition in the Treatment of Small Cell Carcinoma of the Vagina: A Rare Gynecological Tumor.
Case Rep Oncol
; 10(1): 276-280, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28512410
11.
The Case of a Zebra That Was Misdiagnosed as a Horse: Pulmonary Tumor Thrombotic Microangiopathy, a New Paraneoplastic Syndrome, Mimicking PD-1-Induced Pneumonitis.
Case Rep Oncol
; 9(1): 68-75, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-26933422
12.
Partial response to carboplatin in an RRx-001 pretreated patient with EGFR-inhibitor-resistance and T790M-negative NSCLC.
Respir Med Case Rep
; 18: 62-5, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27330954
13.
Partial Response in an RRx-001-Primed Patient with Refractory Small-Cell Lung Cancer after a Third Introduction of Platinum Doublets.
Case Rep Oncol
; 9(2): 285-9, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27403127
14.
Immune Reactivity and Pseudoprogression or Tumor Flare in a Serially Biopsied Neuroendocrine Patient Treated with the Epigenetic Agent RRx-001.
Case Rep Oncol
; 9(1): 164-70, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27065848
15.
RRx-001-Induced Tumor Necrosis and Immune Cell Infiltration in an EGFR Mutation-Positive NSCLC with Resistance to EGFR Tyrosine Kinase Inhibitors: A Case Report.
Case Rep Oncol
; 9(1): 45-50, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-26933418
16.
Partial Response to Platinum Doublets in Refractory EGFR-Positive Non-Small Cell Lung Cancer Patients after RRx-001: Evidence of Episensitization.
Case Rep Oncol
; 9(1): 62-7, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-26933421
17.
RRx-001 in Refractory Small-Cell Lung Carcinoma: A Case Report of a Partial Response after a Third Reintroduction of Platinum Doublets.
Case Rep Oncol
; 9(1): 171-6, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27065849
18.
Conversion of Platinum-Etoposide-Resistant to Sensitive SCLC after Treatment with the Epi-Immunotherapeutic RRx-001: A Case Report.
Oncol Res Treat
; 39(11): 720-723, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27855386
19.
A Partial Response to Reintroduced Chemotherapy in a Resistant Small Cell Lung Cancer Patient After Priming with RRx-001.
Clin Med Insights Oncol
; 10: 105-108, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27840583
20.
Dacomitinib, a new therapy for the treatment of non-small cell lung cancer.
Expert Opin Pharmacother
; 14(2): 247-53, 2013 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-23294134